We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Cencora
COR
$61.2B
| $935K | ﹤0.01% |
7,835
+108
| +1% | +$13K |
|
1027
PTC
PTC
$16B
| $932K | ﹤0.01% |
7,782
-1,085
| -12% | -$145K |
|
1028
Magna International
MGA
$18.8B
| $925K | ﹤0.01% |
12,306
+1,393
| +13% | +$115K |
|
1029
Paycom
PAYC
$9.69B
| $924K | ﹤0.01% |
1,864
+296
| +19% | +$132K |
|
1030
Nuveen ESG Mid-Cap Value ETF
NUMV
$458M
| $923K | ﹤0.01% |
25,450
| – | – |
|
|
AOMR
1031
Angel Oak Mortgage REIT
AOMR
$209M
| $922K | ﹤0.01% |
+54,500
| New | +$968K |
|
1032
Ametek
AME
$58.2B
| $919K | ﹤0.01% |
7,413
-146
| -2% | -$19.6K |
|
1033
Arista Networks
ANET
$238B
| $917K | ﹤0.01% |
42,720
+1,552
| +4% | +$35.6K |
|
1034
Outset Medical
OM
$90.8M
| $917K | ﹤0.01% |
1,237
+169
| +16% | +$115K |
|
1035
BlackRock TCP Capital
TCPC
$345M
| $913K | ﹤0.01% |
67,328
+807
| +1% | +$11.3K |
|
|
ETW
1036
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.06B
| $908K | ﹤0.01% |
84,041
+29,966
| +55% | +$333K |
|
1037
WPP
WPP
$5.94B
| $905K | ﹤0.01% |
13,519
+76
| +0.6% | +$5.09K |
|
1038
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
| $903K | ﹤0.01% |
14,308
+1,199
| +9% | +$73.9K |
|
1039
Halliburton
HAL
$26.6B
| $902K | ﹤0.01% |
41,751
+4,517
| +12% | +$92.5K |
|
1040
Terreno Realty
TRNO
$7.49B
| $901K | ﹤0.01% |
14,266
+49
| +0.3% | +$3.26K |
|
1041
Fomento Económico Mexicano
FMX
$41.7B
| $896K | ﹤0.01% |
10,339
+311
| +3% | +$26.7K |
|
1042
iShares US Infrastructure ETF
IFRA
$4.57B
| $896K | ﹤0.01% |
26,305
+14,664
| +126% | +$522K |
|
1043
Nuveen Credit Strategies Income Fund
JQC
$711M
| $882K | ﹤0.01% |
134,493
-233,402
| -63% | -$1.52M |
|
|
VMEO
1044
DELISTED
Vimeo
VMEO
| $881K | ﹤0.01% |
30,038
+2,442
| +9% | +$96.3K |
|
1045
BlackRock MuniHoldings Fund
MHD
$606M
| $880K | ﹤0.01% |
53,762
+10,321
| +24% | +$176K |
|
1046
Pultegroup
PHM
$25.3B
| $878K | ﹤0.01% |
19,139
-677
| -3% | -$35.2K |
|
1047
VanEck Oil Services ETF
OIH
$1.92B
| $874K | ﹤0.01% |
4,439
+150
| +3% | +$28.5K |
|
1048
Teladoc Health
TDOC
$1.3B
| $872K | ﹤0.01% |
6,884
-637
| -8% | -$92.7K |
|
1049
VICI Properties
VICI
$29.4B
| $868K | ﹤0.01% |
30,582
+11,026
| +56% | +$336K |
|
1050
Cooper Companies
COO
$14.5B
| $864K | ﹤0.01% |
8,376
-64
| -0.8% | -$6.83K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.